PF-04449913 Inhibits Proliferation and Metastasis of Colorectal Cancer Cells by Down-regulating MMP9 Expression through the ERK/p65 Pathway.
Yejiao RuanGuangrong LuYaojun YuYue LuoHao WuYating ShenZejun GaoYao ShenZhenzhai CaiLiyi LiPublished in: Current molecular pharmacology (2023)
Our study provides a new perspective on the potential clinical application of PF-04449913 in the treatment of colorectal cancer.